Aytu Biopharma, Inc.
AYTU
$2.18
$0.010.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 54.71% | -8.03% | 4.45% | 0.72% | -12.96% |
| Total Receivables | 32.43% | 19.72% | -13.60% | -22.50% | -18.70% |
| Inventory | -5.82% | -16.18% | -14.74% | -9.46% | 1.22% |
| Prepaid Expenses | 10.61% | 2.86% | -23.91% | -18.56% | -28.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.93% | 1.94% | -11.65% | -13.97% | -12.93% |
|
|
|||||
| Total Current Assets | 27.93% | 1.94% | -11.65% | -13.97% | -12.93% |
| Net Property, Plant & Equipment | 4.66% | -40.01% | -48.04% | -54.09% | -60.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.55% | -9.93% | -10.33% | -10.70% | -11.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -45.98% | 48.59% | 67.81% | 155.31% | -12.42% |
| Total Assets | 5.15% | -3.62% | -11.45% | -12.84% | -13.46% |
|
|
|||||
| Total Accounts Payable | 2.78% | 14.95% | 11.71% | -6.59% | -23.48% |
| Total Accrued Expenses | -31.43% | -22.52% | -15.70% | -13.27% | -11.97% |
| Short-term Debt | 278.41% | 534.28% | 291.03% | 251.44% | 53.23% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -22.38% | -87.96% | 44.82% | 3,675.81% | 91.29% |
| Total Finance Division Other Current Liabilities | 5.88% | -10.90% | -4.68% | -20.62% | -9.71% |
| Total Other Current Liabilities | 5.88% | -10.90% | -4.68% | -20.62% | -9.71% |
| Total Current Liabilities | 1.34% | -15.51% | -0.22% | -6.43% | -9.83% |
|
|
|||||
| Total Current Liabilities | 1.34% | -15.51% | -0.22% | -6.43% | -9.83% |
| Long-Term Debt | 0.17% | -- | -33.35% | -29.43% | -26.07% |
| Short-term Debt | 278.41% | 534.28% | 291.03% | 251.44% | 53.23% |
| Capital Leases | 70.71% | 27.84% | 30.89% | 1,745.16% | -30.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 81.27% | -40.79% | -43.84% | -35.45% | 33.09% |
| Total Liabilities | 16.41% | -8.95% | -13.14% | -14.61% | -6.93% |
|
|
|||||
| Common Stock & APIC | 1.38% | 0.72% | 0.91% | 1.13% | 1.22% |
| Retained Earnings | -4.24% | 0.52% | -1.68% | -2.00% | -5.21% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -31.57% | 13.39% | -6.36% | -7.28% | -29.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -31.57% | 13.39% | -6.36% | -7.28% | -29.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -31.57% | 13.39% | -6.36% | -7.28% | -29.58% |
|
|
|||||